Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Common Equity: 2012-2025

Historic Common Equity for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to $285.7 million.

  • Phibro Animal Health's Common Equity rose 20.56% to $311.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $311.7 million, marking a year-over-year increase of 20.56%. This contributed to the annual value of $285.7 million for FY2025, which is 11.32% up from last year.
  • Phibro Animal Health's Common Equity amounted to $285.7 million in FY2025, which was up 11.32% from $256.6 million recorded in FY2024.
  • In the past 5 years, Phibro Animal Health's Common Equity registered a high of $285.7 million during FY2025, and its lowest value of $238.5 million during FY2021.
  • Over the past 3 years, Phibro Animal Health's median Common Equity value was $282.5 million (recorded in 2023), while the average stood at $274.9 million.
  • Its Common Equity has fluctuated over the past 5 years, first increased by 26.74% in 2021, then dropped by 9.16% in 2024.
  • Yearly analysis of 5 years shows Phibro Animal Health's Common Equity stood at $238.5 million in 2021, then grew by 10.03% to $262.4 million in 2022, then rose by 7.65% to $282.5 million in 2023, then fell by 9.16% to $256.6 million in 2024, then climbed by 11.32% to $285.7 million in 2025.